当前位置: 首页 > 详情页

Risk factors for pulmonary hypertension in patients receiving maintenance peritoneal dialysis

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Department of Nephrology, The Second Affiliated Hospital of Soochow University, Suzhou, China [2]Department of Hematology, The Second Affiliated Hospital of Soochow University, Suzhou, China
出处:
ISSN:

关键词: Maintenance peritoneal dialysis Pulmonary hypertension End-stage renal disease Internal arteriovenous fistula Hypertensive nephropathy Ejection fraction

摘要:
We investigated the risk factors for pulmonary hypertension (PH) in patients receiving maintenance peritoneal dialysis (MPD). A group of 180 end-stage renal disease patients (124 men and 56 women; mean age: 56.43 +/- 8.36) were enrolled in our study, which was conducted between January 2009 and June 2014. All of the patients received MPD treatment in the Dialysis Center of the Second Affiliated Hospital of Soochow University. Clinical data, laboratory indices, and echocardiographic data from these patients were collected, and follow-ups were scheduled bi-monthly. The incidence and relevant risk factors of PH were analyzed. The differences in measurement data were compared by t-test and enumeration data were compared with the chi(2) test. Among the 180 patients receiving MPD, 60 were diagnosed with PH. The remaining 120 were regarded as the non-PH group. Significant differences were observed in the clinical data, laboratory indices, and echocardiographic data between the PH and non-PH patients (all P<0.05). Furthermore, hypertensive nephropathy patients on MPD showed a significantly higher incidence of PH compared with non-hypertensive nephropathy patients (P<0.05). Logistic regression analysis showed that the proportion of internal arteriovenous fistula, C-reactive protein levels, and ejection fraction were the highest risk factors for PH in patients receiving MPD. Our study shows that there is a high incidence of PH in patients receiving MPD and hypertensive nephropathy patients have an increased susceptibility to PH.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
大类 | 4 区 医学
小类 | 4 区 生物学 4 区 医学:研究与实验
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 生物学 4 区 医学:研究与实验
JCR分区:
出版当年[2014]版:
Q3 BIOLOGY Q4 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q2 BIOLOGY Q3 MEDICINE, RESEARCH & EXPERIMENTAL Q3 BIOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2014版] 出版当年五年平均 出版前一年[2013版] 出版后一年[2015版]

第一作者:
第一作者机构: [1]Department of Nephrology, The Second Affiliated Hospital of Soochow University, Suzhou, China
共同第一作者:
通讯作者:
通讯机构: [1]Department of Nephrology, The Second Affiliated Hospital of Soochow University, Suzhou, China [2]Department of Hematology, The Second Affiliated Hospital of Soochow University, Suzhou, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院